In a model of sepsis-associated AKI, polydatin, another activator of NRF2, was found to mitigate the elevation of serum creatinine and BUN levels by significantly increasing the expression of NRF2 and HO-1. The gene discussed is HMOX1; the disease is acute kidney injury.